Professor George Siemens, University of South Australia https://people.unisa.edu.au/George.Siemens Time: Mar 5th, 5 pm, Eastern time, USA Mar 6th, 8.30 am, Adelaide, Australia Mar 6th, 9 am, Sydney, Australia Mar 6th, 6 am, Hong Kong Mar 5th, 10 pm, London, UK

Computer simulations: significantly reduce the time and cost associated with drug development and improve safety

Quality Throughout the Product Lifecycle

Learn about the rapidly changing environment with AI, types of AI applications, existing barriers, potential enablers, and projected future of AI in the development of medical devices, while evaluating US and European regulatory policies evolving.

The summit will be in person with a virtual option. Location and Zoom link will be emailed after registration. The summit will feature discussions on leadership and assessment. You'll have an opportunity to network too! In person registration closes September 25th.

We live in a digital revolution today witnessing digital transformation happening across all industries including healthcare. The face of healthcare is changing, and so should the skillsets of the regulators.

Sarah Dobney, MPH, is a faculty instructor at The Ohio State University teaching in the regulatory affairs specialization. A medical writer with over 20 years’ experience. She obtained her Bachelor of Arts in Business Administration from Baldwin Wallace College & an MPH in Environmental Health

Career Pathways - Regulatory Affairs and Clinical Research

Our annual summit will feature discussions on leadership and assessment. You'll have an opportunity to network too!

3rd June, 9 pm, Europe 3rd June, 11 pm, Middle East 4th June, 5 am, Sydney, Australia Join Dr. Gert Bos, CSO of Qserve Group and Ebrahim Najjar, Regulatory Affairs Senior Specialist at Roche Middle East to learn the latest on EUMD.

Learn from fellow educators the skills to make you a more effective online educator and the importance of collaboration in our field - in the classroom, lab and conference room.

Accelerated Regulatory Approval Pathways and Their Impact on Access to Medicines in Australia and Digital Health Trends for Research Professionals

Collaboration between US Food & Drug Administration and Australia Therapeutic Goods Administration

Dr. Chisolm is an associate professor at The University of New South Wales. She is an active member in the university's Educational Research and Development Group.

What did we learn about EUA during the global pandemic?